Survivor Views

Share

Three Cancer Survivors

Cancer Survivors’ Views Make a Difference

Survivor Views is a groundbreaking program designed to further engage cancer survivors in the important policy issues that are part of ACS CAN’s fight against cancer.  Over 3,000 cancer survivors have agreed to participate in Survivor Views by responding to regular surveys on policy issues that support the prevention, detection and treatment of cancer and promote survivors’ quality of life.

Through Survivor Views, ACS CAN hears directly from cancer survivors about their experiences and their perspectives on critical cancer-related issues.  This information helps shape the development of policy positions and provides important evidence to support the enactment of these policies.

51%

of cancer patients and survivors have gone into debt to cover the cost of their cancer care.

View the survey findings

Latest Updates

May 11, 2023
National

A majority (58%) of cancer patients and survivors say they would be less likely to remain current with their recommended preventive care if it came with a cost, according to a new survey by the American Cancer Society Cancer Action Network (ACS CAN). Over half (53%) of those surveyed quantified the cost that would present such a barrier at less than $200, with more than a quarter (28%) marking their threshold at $100.

February 16, 2023
National

According to the most recent Survivor Views survey, cost is considered the most important factor when it comes to comparing coverage options (43%), but the right mix of covered benefits is also essential.

October 10, 2022

Female cancer patients are less satisfied with the quality of their cancer care than male cancer patients and are more likely to report that their symptoms were not taken seriously and that they had to prove their symptoms to providers.

July 19, 2022
New York

Albany, NY – A new Survivor Views survey from the American Cancer Society Cancer Action Network (ACS CAN) shows that while copay assistance programs can help cancer patients afford the medications they need, some aren’t able to apply them to their health insurance deductible or other out-of-pocket requirements,

Survivor Views Resources

Our latest survey finds that cancer patients and survivors would be less likely to stay current with preventive care, including recommended cancer screenings, if the provision requiring these services be covered at no cost were repealed. This survey also explores the challenges of limited provider networks and the need for patient navigation.

Cancer patients and survivors must balance reducing their health care costs with ensuring they have comprehensive coverage of services, treatments, and care providers.

Our latest survey finds that female cancer patients are less satisfied with the quality of their cancer care than male cancer patients and are more likely to report that their symptoms were not taken seriously and that they had to prove their symptoms to providers.

Prescription drug costs are a significant burden on cancer patients and survivors, sometimes even leading patients to miss or delay taking prescribed medications. The latest Survivor Views survey explores the role copay assistance programs can play in reducing this burden, and also addresses patient navigation and digital therapeutics.

Cancer Debt InfographicNearly three-quarters of cancer patients and survivors are worried about their ability to pay for their care and 51% have gone into debt as a result of their costs. The debt burden extends across insurance types and income levels, with women and Black cancer patients more likely to report medical debt.

The cost of cancer care is substantially impacting the lives of cancer patients and survivors. Our latest survey finds that half report incurring cancer-related medical debt and nearly three-quarters are worried about their ability to pay for needed care. The impacts of medical debt on cancer patients range from facing collections and lowered credit scores to avoiding treatment for medical issues, with unequal burden across populations.




Survivor Views is made possible by support from Bristol Myers Squibb, Amgen, Merck, Pfizer, and Sanofi